ArticleJournal of multidisciplinary healthcare2025
Hospital-at-Home in Taiwan: Reducing Hospital Stay and Medical Expenditures.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outpatient Parenteral Antimicrobial Therapy in Asia: Evolution, Models, and Challenges over the Past Decade-A Narrative Review.Antibiotics (Basel, Switzerland) · 2026Review
- Digital Governance at the Street Level: A Mixed-Methods Study of Systemic Resilience and 'Human-in-the-Loop' Telemedicine in Rural Thailand.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hospital-at-Home (HaH) is an alternative care model that delivers hospital-level treatment at home, improving patient outcomes while reducing healthcare costs. Despite its success globally, HaH was not implemented in Taiwan until the initiation of a pilot program. This study evaluates the outcomes of HaH compared to traditional hospitalization. Methods: A retrospective cohort study was conducted at a tertiary medical center in Taiwan. HaH patients diagnosed with pneumonia, urinary tract infection, or soft tissue infection between August 1, 2024, and January 31, 2025, were included (n = 69). A matched hospitalized cohort (n = 246) was selected based on age, sex, and diagnosis. Outcomes, including length of stay, medical expenditure, emergency department (ED) visits, rehospitalization, and patient satisfaction, were analyzed using univariate and logistic regression analyses. Results: The HaH cohort had a significantly shorter length of stay (adjusted OR: 0.53, 95% CI: 0.30-0.93, p = 0.028) and lower medical expenditure (adjusted OR: 0.18, 95% CI: 0.10-0.33, p < 0.001). HaH patients were more likely to transition to home healthcare (73.9% vs 7.3%, p < 0.001), and satisfaction was 100%. No significant differences were found in ED visits or rehospitalization rates between the two cohorts (all p > 0.05). Conclusion: HaH is an effective alternative to hospitalization, reducing length of stay and medical expenses while maintaining patient safety and satisfaction. Expanding HaH to additional conditions could further enhance healthcare efficiency. These findings highlight HaH's feasibility in Taiwan and its role in healthcare resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.